Navigation Links
Vasogen Announces Second Quarter 2009 Results
Date:7/14/2009

monetization of certain tangible and intangible assets. The process has also included a review of the potential out-licensing of assets, lapsing of patents and patent applications, asset divestiture, or liquidation of the Company. The process involved narrowing down the number of third-party proposals. At this time, we are in the process of negotiating agreements that may result in one or more transactions with regard to the foregoing. There can be no assurances that we will be able to finalize any such agreements. The Board will also consider alternatives to these that it has also been evaluating. The Board will continue to assess the merits of these options relative to liquidating the Company and distributing the remaining cash to the shareholders.

The unaudited interim consolidated financial statements, accompanying notes to the unaudited interim consolidated financial statements, and Management's Discussion and Analysis for the three and six months ended May 31, 2009, will be accessible on Vasogen's website at www.vasogen.com and will be available on SEDAR and EDGAR.

Certain statements in this document constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and/or "forward-looking information" under the Securities Act (Ontario). These statements may include, without limitation, plans to consider a sale, merger, acquisition, or other alternatives resulting from our strategic review, statements regarding the status of development, or expenditures relating to the Celacade System or our VP series of drugs including VP015 and VP025, plans to fund our current activities, statements concerning our partnering activities, health regulatory submissions, strategy, future operations, future financial position, future
'/>"/>

SOURCE Vasogen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Vasogen Announces 2007 Year-End Results
8. The Lancet Publishes Vasogens ACCLAIM Results
9. Vasogens Research Published in European Journal of Neuroscience
10. Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel
11. Vasogen Provides Update on ACCLAIM II Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Reprints Desk, Inc., a Research Solutions (OTCQB: ... scientific, technical and medical (STM) content, today announced a ... Southeastern Research Libraries (ASERL) . ASERL is ... southeastern states. Founded in 1956, ASERL has a long ... the continually changing needs of its member libraries. ...
(Date:5/5/2015)... USA (PRWEB) May 05, 2015 A ... covering a wide range of key photonics technologies – ... global competitiveness of U.S. industry. To help the community ... on 12 May on the proposed changes to ... commodities covered by International Traffic in Arms Regulations (ITAR). ...
(Date:5/5/2015)... May 05, 2015 Research and Markets ... of the "Clinical Laboratory, Molecular Diagnostics and ... to 2019 - Europe Version" report to ... in the area of molecular diagnostics and pharmacogenics ... evolving world market that is moving out of ...
(Date:5/5/2015)... , May 5, 2015   Tocagen Inc. ... David R. Parkinson , M.D., a venture ... appointed to the board of directors of Tocagen. ... experience in oncology clinical development, including leading clinical ... global approvals of the cancer therapeutics Gleevec®, Femara®, ...
Breaking Biology Technology:Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 2Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 3Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 4Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4European Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4
... VIRxSYS Corporation, a,privately held company developing gene ... a privately-owned biotechnology company,focused on the manufacture and ... agreed to settle the pending litigation between,the two ... counterclaims,asserted in the lawsuit, which has been pending ...
... to ... Meet Growing Global Demand, WILMINGTON, Del., ... C. Fanandakis group vice president - DuPont Applied,BioSciences. In this ... commercialize a range of bio-based,products and technologies to meet growing ...
... (Nasdaq and MTAX: CTIC) today announced that the ... granted authorization to,publish the Italian listing prospectus, according ... Article 56 of the CONSOB Regulation no. 11971/99,relating ... than 10% of,the shares of common stock currently ...
Cached Biology Technology:VIRxSYS and Lentigen Announce Litigation Settlement 2DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences 2Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus 2Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus 3
(Date:4/2/2015)... -- Fingerprint Cards (FPC) has received an ... distributor World Peace Industrial Group (WPI), part of WPG ... major part of the shipments will take place during ... manufacturers in China . The order ... revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:4/1/2015)...   Medisafe ™, the leading global medication management ... and Android smartphones and tablets, announces ... platform to allow patients to track and correlate their ... patients will be able to visualize in real-time how ... such as glucose levels and blood pressure. ...
(Date:3/31/2015)... 2015   Guidepoint , a leading global research ... Pain Management TRACKER, part of the Guidepoint TRACKER ... the medical device and therapeutics markets. The Post-Surgical Pain ... volumes, market share, and adoption rates across three major ... surgery. The Post-Surgical Pain Management TRACKER will ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... June 27th, 2010 The Elsevier Foundation, TWAS and ... women scientists from Africa, the Middle East, Asia, Latin ... announcement was made at the Third World Organization for ... Conference, Women Scientists in a Changing World, hosted by ...
... tropical forests so biologically rich? Smithsonian researchers have new ... mysteries lies underground, according to a study published in the ... that tree seedlings do not grow and survive well under ... said Scott Mangan, postdoctoral fellow at the University of WisconsinMilwaukee ...
... The July issue of GEOLOGY presents studies ... river dataset examining whether the sedimentological record can help document ... development of the NW British continental margin, how rivers react ... GSA TODAY looks at individual mineral grains as ...
Cached Biology News:12 women scientists announced as winners of Elsevier Foundation TWOWS Awards 2Biodiversity's holy grail is in the soil 2July 2010 Geology and GSA Today highlights 2July 2010 Geology and GSA Today highlights 3July 2010 Geology and GSA Today highlights 4July 2010 Geology and GSA Today highlights 5July 2010 Geology and GSA Today highlights 6July 2010 Geology and GSA Today highlights 7July 2010 Geology and GSA Today highlights 8July 2010 Geology and GSA Today highlights 9July 2010 Geology and GSA Today highlights 10July 2010 Geology and GSA Today highlights 11July 2010 Geology and GSA Today highlights 12July 2010 Geology and GSA Today highlights 13July 2010 Geology and GSA Today highlights 14July 2010 Geology and GSA Today highlights 15
... formulated to support the growth of cells ... eucalypti. The medium is a modification of ... cell lines established by Grace using this ... The basal medium, when properly supplemented, has ...
... trays and universal trays make vessel ... Shaking speed: 40 - ... amplitude Clamps for Erlenmeyer ... including Fernbach flasks Hinged ...
...
GLP expression profiling service on the Affymetrix platform. Starting material can be blood, tissue or RNA. 5 day turnaround. Standard and custom post analyses of microarray data available....
Biology Products: